Alector, Inc.
- ALEC
- NASDAQ
- Biotechnology
- Immuno-Neurology
- Neurodegenerative Disease Therapies
$1.84
Today −3.66%Quote Oct 16, 2026, 08:00 PM UTC
−0.54%over the last month
Max drawdown −11.5%From 1-month high −11.5%3 months +28.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$205.4M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$2.25
+22.3% from here
Floor
$1.74
5.4% below price
Where the price sits
14 analysts
Analyst range, low to high
$1.50$3.00
- Price $1.84
- Resistance $1.92
- Consensus $2.25
Analysts' average target sits about 22% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ALECPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
103